Legal Opinion
Bradley v. ARIAD Pharmaceuticals, Inc.
Court of Appeals for the First Circuit
Decided November 28, 2016No. 15-1491PPublishedCited by 51 opinions
1Opinion of the Court
' HOWARD, Chief Judge.
When a company’s stock declines, a shareholder lawsuit often follows. This case is no exception. Following a drop in the share price of ARIAD Pharmaceuticals, Inc., investors filed suit against the company and four corporate officers (together “ARIAD”), alleging securities fraud in violation of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (“Exchange Act”), 15 U.S.C. §§ 783(b) and 78t(a), as well as the Securities and Exchange Commission’s (“SEC”) Rule 10b-5, 17 C.F.R. § 240.10b-5. The complaint also raised claims under Sections 11 and 15 of the…
2Cases cited25 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Tellabs, Inc. v. Makor Issues & Rights, Ltd.Supreme Court of the United States · 2007
- Ernst & Ernst v. HochfelderSupreme Court of the United States · 1976
- Basic Inc. v. LevinsonSupreme Court of the United States · 1988
20 more not listed; retrieve them via the Exa API.
3Cited by51 opinions
- In Re: Biogen Inc. Sec. Litig. v.Court of Appeals for the First Circuit · 2017
- Brennan v. Zafgen, Inc.Court of Appeals for the First Circuit · 2017
- Ganem v. Invivo Therapeutics Holdings Corp.Court of Appeals for the First Circuit · 2017
- In Re: Ocular Therapeutix Inc v.Court of Appeals for the First Circuit · 2020
- Shash v. Biogen Inc.Court of Appeals for the First Circuit · 2023
46 more not listed; retrieve them via the Exa API.